Strategy for Designing a Synthetic Tumor Vaccine: Multi-Component, Multivalency and Antigen Modification

Vaccines
Zhi-Hua HuangYan-Mei Li

Abstract

Synthetic tumor vaccines have been proven to be promising for cancer immunotherapy. However, the limitation of the specificity and efficiency of the synthetic tumor vaccines need further improvements. To overcome these difficulties, additional tumor-associated targets need to be identified, and optimized structural designs of vaccines need to be elaborated. In this review, we summarized the main strategies pursued in the design of synthetic tumor vaccines, such as multi-component, multivalency, antigen modification and other possible ways to improve the efficiency of synthetic tumor vaccines.

References

Mar 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·H NakadaI Yamashina
Nov 24, 1999·Immunological Reviews·R F Wang, S A Rosenberg
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·V KudryashovK O Lloyd
Mar 23, 2002·Biochimica Et Biophysica Acta·Tsuneyasu Kaisho, Shizuo Akira
Aug 23, 2002·Cancer Immunology, Immunotherapy : CII·Stephen WardStephen Todryk
Sep 25, 2002·Microbes and Infection·Clett ErridgeIan R Poxton
Oct 31, 2002·Nature Immunology·Gavin P DunnRobert D Schreiber
Jul 2, 2004·Nature Reviews. Immunology·Shizuo Akira, Kiyoshi Takeda
Jul 2, 2004·Nature Reviews. Immunology·Bruno Lemaitre
Jul 29, 2004·Proceedings of the National Academy of Sciences of the United States of America·Stacy J Keding, Samuel J Danishefsky
Apr 22, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Govind RagupathiPhilip O Livingston
Jul 12, 2005·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Uwe KarstenSteffen Goletz
Feb 24, 2007·Nature Reviews. Immunology·Giorgio Trinchieri, Alan Sher
Apr 27, 2007·Nature·Danica P Galonić, David Y Gin
Jun 15, 2007·Nature Reviews. Microbiology·Bruno Guy
Sep 4, 2007·Nature Chemical Biology·Sampat IngaleGeert-Jan Boons
Nov 21, 2007·Cancer Biology & Therapy·Ravibhushan Singh, Dilip Bandyopadhyay
Apr 11, 2008·Critical Reviews in Oncology/hematology·Sharmila Pejawar-Gaddy, Olivera J Finn
Jun 28, 2008·Cancer Immunology, Immunotherapy : CII·Ilham BettahiLbachir BenMohamed
Jan 16, 2009·Chembiochem : a European Journal of Chemical Biology·Sampat IngaleGeert-Jan Boons
Jun 13, 2009·Journal of the American Chemical Society·Jianglong ZhuSamuel J Danishefsky
Sep 22, 2009·Current Opinion in Chemical Biology·Zhongwu Guo, Qianli Wang
Nov 17, 2009·Trends in Biochemical Sciences·Shantibhusan SenapatiSurinder K Batra
Mar 18, 2010·Chemical Communications : Chem Comm·Hamilton KakwereSébastien Perrier
Jul 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Xiangming LiMoriya Tsuji
Jul 20, 2010·Immunotherapy·Richard E BeatsonJoy M Burchell
Sep 8, 2010·Angewandte Chemie·Mariusz SkwarczynskiIstvan Toth
Sep 9, 2010·Expert Review of Vaccines·Moses O OyewumiZhengrong Cui
Oct 16, 2010·Nature Reviews. Immunology·Martin F Bachmann, Gary T Jennings
Dec 7, 2010·Chembiochem : a European Journal of Chemical Biology·Arin GhasparianJohn A Robinson

❮ Previous
Next ❯

Methods Mentioned

BETA
glycosylation
transfection
xenograft
glycosylations

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

New York State Journal of Medicine
J J Barlow, M Bhattacharya
Experimental Oncology
G P PotebnyaG S Lisovenko
Pharmacology & Therapeutics
B R MinevM S Mitchell
© 2021 Meta ULC. All rights reserved